For example, among genes considered to be of moderate penetrance, such as CHEK2 and ATM, there are specific variants identified in these genes that deviate from the 2–4-fold risk of BC typically imparted by PVs in these genes69–71. This evidence concerns the gene CHEK2 and breast cancer.